SHARING LIFE SKILLS =
Accepting Treatment Adherence

What does adherence mean?

  • Adherence means taking doses of drugs and sticking to the treatment plan – or ‘treatment regimen’ - exactly as prescribed.
  • Adherence means taking the correct dose of drugs, at the correct time and in the correct way (for example, with the right type of food or fluid, and before or after a meal).
  • Adherence also involves looking after drugs to make sure that they are effective and safe to use.

Why is it important for a person with HIV to adhere to ARV treatment?

  • If ARV treatment is used correctly, it can improve a person’s health and quality of life and enable them to live for a long time.
  • If adherence is very good, the amount of HIV in a person’s body will reduce very quickly after a few weeks or months. This allows their immune system to start to recover, so that illness is reduced and health is regained.
  • A very high level of adherence (at least 95%) is necessary for ARV treatment to work effectively. Missing even a few doses of drugs can cause treatment to fail and opportunistic infections or drug resistance to develop.

What happens if a person’s adherence to ARV treatment is not good enough?

  • Failure to adhere to ARV treatment might involve a person:
    • Missing one or two doses of drugs occasionally.
    • Stopping the treatment completely.
    • Taking smaller doses of drugs than the amount prescribed. This might be because they are worried about side effects, lack money to pay for more drugs or are sharing treatment with another person.
  • Poor adherence to ARV treatment allows a person’s levels of HIV to stay high and their immune system to stay weak. It means that they face an increased risk of severe illness, more time in hospital and early death.
  • Poor adherence can also cause the virus to become resistant to ARVs. This means that the treatment stops working and there is more risk of the person becoming ill. Drug resistant HIV can be transmitted to other people, increasing their risk of illness and making their treatment difficult.
  • If treatment fails or the virus becomes resistant, it is necessary to change to a different set of drugs (called ‘second-line’ drugs) for combination therapy or highly active anti-retroviral therapy (HAART). These drugs are often more expensive, the regimen will be more complicated and, as a result, it is more difficult to adhere to them.

Why might a person fail to adhere to ARV treatment?

  • Most people – especially those living with a chronic health problem – miss some doses of their drugs sometimes.
  • Some of the common reasons why a person with HIV misses a dose of ARVs include: forgetting; being busy; falling asleep; being depressed; and being away from home and out of the usual routine.
  • There are many reasons why a person might have difficulty with their ARV treatment and, as a result, fail to adhere to it or decide to stop it. Reasons include: worries about side effects; finding the regimen too complicated, such as too many pills at too many different times; difficulties fitting pill-taking into family and work life; being tired of taking long-term treatment; or having strong anti-treatment health beliefs.
  • If a person wants to stop treatment, they must discuss it fully with their doctor before making any final decision.
Helping a person to get better is the most effective way to support adherence. It proves that treatment is worthwhile and encourages them to keep taking their ARVs correctly.

What can help a person to adhere to ARV treatment?

Ways of helping a person with adherence include:

  • Involving the person who has to take treatment in decisions about their treatment.
  • Having a good relationship between the person on treatment and their treatment provider.
  • Finding out what beliefs a person has about HIV and ARV treatment, discussing them and correcting any false information. This might involve addressing specific issues, such as someone’s lack of trust in medication or beliefs that ARVs are poisonous.
  • Providing clear and accurate information about HIV and ARVs that is appropriate for a person’s specific needs. This includes: what treatment can and cannot do; what to do about side effects; what to do to ensure adherence and prevent drug resistance; and what happens if treatment has to be changed.
  • Providing a person with access to counselling and support from health workers and other treatment supporters.
  • Regularly monitoring the progress of the treatment - through clinical check-ups and asking specific questions about adherence.
  • Assessing and doing something about the person’s psychosocial concerns. These might include: stress; depression; drug and alcohol use; food; housing; childcare; lack of disclosure of HIV status; and stigma and discrimination.
  • Involving a wide range of people – such as family, friends, other people with HIV and community leaders – in supporting a person to adhere to their treatment.
  • Providing opportunities for a person to share their experiences with other people who are taking ARVs successfully. This might be through a ‘buddy’ system or a self-help group.
  • Making the treatment regimen as simple as possible. For example, where possible, reducing the number of pills and linking doses to a person’s daily routine.
  • Providing methods to help a person remember their doses. These might include diaries, charts, alarms, text messages, emails or pill boxes.

What can help a person who has difficulty with adherence to ARV treatment?

  • Having a non-judgemental approach and accepting that almost everyone misses doses of drugs sometimes.
  • Assessing and building a person’s overall motivation for treatment.
  • Checking a person’s adherence by asking specific but open questions such as: “In the last month, how many doses do you think you missed?”
  • Clarifying and checking a person’s understanding of their drug regimen.
  • Addressing a person’s patterns of non-adherence. For example, looking at whether non-adherence is associated with particular social situations, behaviours or thoughts.
  • Providing a person with additional support when needed – to help them remember their doses, talk about their experiences and encourage them to continue their treatment.
Key points on supporting adherence to ARV treatment?
  • Integrate adherence monitoring and support into the continuum of care, support, treatment and prevention for a person with HIV.
  • Provide adherence support over the long term, not just at the beginning of treatment.
  • Provide ongoing training and support for health workers and others involved in adherence support.
  • Develop a written adherence support policy for health workers and others supporting people with HIV on ARV treatment.
  • Adapt ways of providing adherence support to individuals and their changing circumstances.

 

Research courtesy the International HIV AIDS Alliance
Supporting Community Action in Developing Countries

www.aidsalliance.org

All rights reserved.

 

 

Treatment Guide to some HIV Medications available in the Caribbean

IMPORTANT FACT: None of the following Antiretrovirals listed here eliminate HIV or AIDS or totally restore the immune system. There is still a danger of serious infections, so you should be sure to see your doctor regularly for monitoring and tests. Notify your doctor immediately of any changes in your general health.

Remember there is no cure for HIV and AIDS and Treatment does not eliminate the danger of transmitting the virus to others.

Retrovir

Pronounced: reh-troh-VEER
Generic name: Zidovudine

Retrovir is prescribed for adults infected with human immunodeficiency virus (HIV). Retrovir slows down the progress of HIV. Combining Retrovir with other drugs such as Epivir and Crixivan can help slow the progression. Retrovir is also prescribed for HIV-infected children over 3 months of age who have symptoms of HIV or who have no symptoms but, through testing, have shown evidence of impaired immunity. Retrovir taken during pregnancy often prevents transmission of HIV from mother to child.

Kaletra

Pronounced: cuh-LEE-tra
Generic ingredients: Lopinavir, Ritonavir

Kaletra is a combination of two drugs, lopinavir and ritonavir (Norvir), both of which fall into the drug category known as protease inhibitors. When taken along with other HIV drugs, Kaletra lowers the amount of the virus circulating in the bloodstream. However, it does not completely eradicate the virus, and you may continue to develop the rare infections that attack when the immune system weakens.

> View all medications

Research and Graphics provided by Health Square

For more details check out: healthsquare.com

NOTICE: Health Square is solely to be used as an informational resource and should never be used to replace contact with your licensed healthcare provider.
All rights reserved.